Global Markets for Medical Imaging Reagents and Analysis Equipment

REPORT HIGHLIGHTS

This report provides:

• An overview of the medical imaging and diagnosing markets
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Discussion of each market and its applications by its need for diagnosis through imaging, regulatory environment, technology involved, market projections, and market share
• Examination of technological issues, including the latest trends and developments
• Acquisition strategies and collaborations by companies
• Evaluations of the strengths and weaknesses of each system/technology in light of new technologies, growing competition, and changing customer needs
• Comprehensive company profiles of key players in the industry.

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging technologies, which includes both the imaging systems and the contrast agents. The key objective is to present a comprehensive analysis and future direction of imaging techniques as an important tool for the usage in medical diagnostic procedures.

This report explores present and future strategies within the medical imaging technology market, which includes X-ray imaging, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. The improvisation of the market as well as the setbacks and needs of the market are discussed in this report. The classifications, comparisons, advantages and disadvantages and usage of these types of diagnostic methods are also listed in this report.

A detailed analysis of medical imaging industry structure has been conducted. Revenues are broken down by the region and sales figures are estimated for the five-year period from 2011 through 2017.

Applications for medical imaging technologies are also discussed separately in the report, with an emphasis of the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

Extensive research and new developments in the field of medical imaging technology has improved their usage in being able to be used as a prime diagnostic tool for various diseases and other medical conditions. Modern industries continue to explore the advantages of medical imaging technologies, leading to the steady market growth due to higher production of the imaging systems. This study is an update to the one published in January 2010.

R&D spending, along with increasing competition, new technologies, new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE

This study contributes to the areas of market growth in medical imaging (imaging systems and contrast agents) product manufacturers and users. Pharmaceutical, biotechnical companies, research institutes, hospitals and physicians will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of imaging systems and contrast agents technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

TABLE OF CONTENTS

Chapter- 1: INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY
Table Summary : GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017
Figure Summary : GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017

Chapter- 3: OVERVIEW
DEFINITIONS
TYPES OF MEDICAL IMAGING
COMPARISON OF VARIOUS IMAGING MODALITIES
CONTRAST AGENTS
IMAGING EQUIPMENT

Chapter- 4: REGULATORY ISSUES
APPROVALS IN THE FIELD OF MEDICAL IMAGING
RECALLS
APPROVALS FOR CONTRAST AGENTS
SAFETY ALERTS

Chapter- 5: NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS
Table 29 : NEW DEVELOPMENTS IN CONTRAST AGENTS
Table 30 : NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY
Table 31 : NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING
Table 32 : NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY
Table 33 : NEW DEVELOPMENTS IN ULTRASOUND
Table 34 : NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND FLUOROSCOPY)

Chapter- 6: GLOBAL MARKET ANALYSIS FOR IMAGING TECHNOLOGIES
MARKET FOR CONTRAST AGENTS BY IMAGING TECHNOLOGY
MARKET FOR IMAGING SYSTEMS BY IMAGING TECHNOLOGY
GLOBAL MARKET FOR CONTRAST AGENTS BY REGION
MARKET FOR IMAGING SYSTEMS BY REGION
MARKET BY APPLICATIONS

Chapter- 7: MARKET ANALYSIS FOR X-RAYS AND COMPUTED TOMOGRAPHY
MARKET FOR CONTRAST AGENTS BY REGION
MARKET BY TYPE OF IMAGING SYSTEMS
MARKET FOR X-RAY IMAGING SYSTEMS BY REGION
MARKET FOR CT IMAGING SYSTEMS BY REGION
MARKET BY APPLICATIONS
INDUSTRY STRUCTURE

Chapter- 8: MARKET ANALYSIS FOR MAGNETIC RESONANCE IMAGING
MARKET FOR CONTRAST AGENTS BY REGION
MARKET FOR IMAGING SYSTEMS BY REGION
MARKET BY MAGNETIC STRENGTH
MARKET BY APPLICATIONS
INDUSTRY STRUCTURE

Chapter- 9: MARKET FOR ULTRASOUND IMAGING
MARKET FOR CONTRAST AGENTS BY REGION
MARKET FOR IMAGING SYSTEMS BY REGION
MARKET BY APPLICATIONS
INDUSTRY STRUCTURE

Chapter- 10: MARKET FOR POSITRON EMISSION TOMOGRAPHY
MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION
MARKET FOR IMAGING SYSTEMS BY REGION
MARKET BY APPLICATIONS
INDUSTRY STRUCTURE

Chapter- 11: PATENT ANALYSIS
CONTRAST AGENTS
IMAGING SYSTEMS

Chapter- 12: DEMAND AND USE
CONTRAST AGENTS MARKET
REGULATORY ISSUES
BABY BOOMER GENERATION
INCREASING INCIDENCE OF LIFE-THREATENING DISEASES
COMPETITION
TECHNOLOGICAL ADVANCEMENTS
SETBACKS IN INDUSTRY
TRENDS IN THE IMAGING SYSTEMS MARKET

Chapter- 13: COMPANY PROFILES
AMAG PHARMACEUTICALS INC.
ANALOGIC CORPORATION
BAYER HEALTHCARE PHARMACEUTICALS
BRACCO IMAGING SPA
COVIDIEN
ECHOSON SA (PL)
ESAOTE S.P.A
FONAR CORPORATION
GE HEALTHCARE
GUERBET LLC
HITACHI MEDICAL CORPORATION
HOLOGIC INC
LANTHEUS MEDICAL IMAGING
MILLENIUM TECHNOLOGIES LTD.
NORDION
PARADIGM MEDICAL INDUSTRIES INC.
PARAMED MEDICAL SYSTEMS INC.
PHILIPS HEALTHCARE
POSITRON CORPORATION
SAMSUNG MEDISON AMERICA INC
SHIMADZU CORPORATION
SIEMENS AG
SONOSITE INC
TELEMED LTD.
TERASON ULTRASOUND
TIME MEDICAL INC.
TOMTEC IMAGING SYSTEMS
TOSHIBA MEDICAL SYSTEMS CORPORATIONS
TRIAD ISOTOPES INC.
ULTRASONIX MEDICAL CORP.
VOLCANO CORPORATION
ZONARE MEDICAL SYSTEMS INC.

Chapter- 14: APPENDIX I-ABBREVIATIONS

LIST OF TABLES

Summary Table : GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017
Table 1 : HISTORY AND DEVELOPMENT OF X-RAY IMAGING
Table 2 : ADVANTAGES AND DISADVANTAGES OF X-RAY
Table 3 : HISTORY AND DEVELOPMENT OF ULTRASOUND
Table 4 : ADVANTAGES AND DISADVANTAGES OF ULTRASOUND
Table 5 : HISTORY AND DEVELOPMENT OF MRI
Table 6 : ADVANTAGES AND DISADVANTAGES OF MRI
Table 7 : ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY
Table 8 : HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY
Table 9 : ADVANTAGES AND DISADVANTAGES OF PET
Table 10 : DIFFERENCES BETWEEN CT AND MRI
Table 11 : DIFFERENCES BETWEEN CT AND ULTRASOUND
Table 12 : DIFFERENCES BETWEEN CT AND PET
Table 13 : DIFFERENCES BETWEEN MRI AND X-RAY
Table 14 : ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM
Table 15 : NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS
Table 16 : LIVER-SPECIFIC CONTRAST AGENTS
Table 17 : COMMONLY USED RADIOPHARMACEUTICALS
Table 18 : NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012
Table 19 : 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008 - AUGUST 2012
Table 20 : 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012
Table 21 : 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008 - AUGUST 2012
Table 22 : 510(K) APPROVALS FOR PET SYSTEMS, 2008 - AUGUST 2012
Table 23 : RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS
Table 24 : RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS, 2008 - SEPTEMBER 2012
Table 25 : RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012
Table 26 : RECALLS FOR PET SYSTEMS, 2008 - SEPTEMBER 2012
Table 27 : APPROVAL OF CONTRAST AGENTS
Table 28 : SAFETY ALERTS FOR CONTRAST AGENTS, 2008 - SEPTEMBER 2012
Table 29 : NEW DEVELOPMENTS IN CONTRAST AGENTS
Table 30 : NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY
Table 31 : NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING
Table 32 : NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY
Table 33 : NEW DEVELOPMENTS IN ULTRASOUND
Table 34 : NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND FLUOROSCOPY)
Table 35 : GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, THROUGH 2017
Table 36 : GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY 2011
Table 37 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH 2017
Table 38 : MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011
Table 39 : GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017
Table 40 : GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011
Table 41 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017
Table 42 : GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011
Table 43 : GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 44 : GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011
Table 45 : GLOBAL MARKET FOR X-RAY AND CT AGENTS BY REGION, THROUGH 2017
Table 46 : MARKET SHARE OF X-RAY AND CT REAGENTS BY REGION, 2011
Table 47 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY TYPE, THROUGH 2017
Table 48 : MARKET SHARE OF IMAGING SYSTEMS BY TYPE, 2011
Table 49 : GLOBAL MARKET FOR X-RAY SYSTEMS BY REGION, THROUGH 2017
Table 50 : MARKET SHARE OF X-RAY SYSTEMS BY REGION, 2011
Table 51 : GLOBAL MARKET FOR COMPUTED TOMOGRAPHY SYSTEMS BY REGION, THROUGH 2017
Table 52 : MARKET SHARE OF COMPUTED TOMOGRAPHY SYSTEMS BY REGION, 2011
Table 53 : GLOBAL REVENUE FOR X-RAY AND CT REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 54 : GLOBAL REVENUE FOR X-RAY AND CT REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 55 : X-RAY IMAGING MARKET SHARES, BY APPLICATION, 2011
Table 56 : GLOBAL REVENUE FOR CT REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 57 : COMPUTED TOMOGRAPHY IMAGING MARKET SHARES, BY APPLICATION, 2011
Table 58 : LEADING MANUFACTURERS OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS
Table 59 : GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2011
Table 60 : LEADING MANUFACTURERS OF RADIOGRAPHY (X-RAY, FLUOROSCOPY AND MAMMOGRAPHY) IMAGING SYSTEMS
Table 61 : GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2011
Table 62 : LEADING MANUFACTURERS OF COMPUTED TOMOGRAPHY SYSTEMS
Table 63 : WORLDWIDE MARKET SHARES OF COMPUTED TOMOGRAPHY SYSTEMS, 2011
Table 64 : GLOBAL MARKET FOR MRI AGENTS, BY REGION, THROUGH 2017
Table 65 : MARKET SHARE OF MRI REAGENTS BY REGION, 2011
Table 66 : GLOBAL MARKET FOR MRI SYSTEMS, BY REGION, THROUGH 2017
Table 67 : MARKET SHARE OF MRI SYSTEMS, BY REGION, 2011
Table 68 : GLOBAL MARKET FOR MRI SYSTEMS, BY MAGNETIC STRENGTH, THROUGH 2017
Table 69 : GLOBAL REVENUE FOR MRI REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 70 : MAGNETIC RESONANCE IMAGING MARKET SHARES, BY APPLICATION, 2011
Table 71 : LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS
Table 72 : GLOBAL MARKET SHARES OF MRI CONTRAST AGENTS, 2011
Table 73 : LEADING MANUFACTURERS OF NUCLEAR MAGNETIC IMAGING SYSTEMS
Table 74 : GLOBAL MARKET SHARES OF MRI IMAGING SYSTEMS, 2011
Table 75 : GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, THROUGH 2017
Table 76 : MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011
Table 77 : GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, THROUGH 2017
Table 78 : MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011
Table 79 : GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017
Table 80 : ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011
Table 81 : LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS
Table 82 : GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011
Table 83 : LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS
Table 84 : GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011
Table 85 : GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2017
Table 86 : MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011
Table 87 : GLOBAL MARKET FOR PET SYSTEMS, BY REGION, THROUGH 2017
Table 88 : MARKET SHARE OF PET SYSTEMS BY REGION, 2011
Table 89 : GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, THROUGH 2017
Table 90 : POSITRON EMISSION TOMOGRAPHY IMAGING MARKET SHARES, BY APPLICATION, 2011
Table 91 : LEADING MANUFACTURERS OF DIAGNOSTIC RADIOPHARMACEUTICALS
Table 92 : WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, 2011
Table 93 : LEADING MANUFACTURERS OF PET IMAGING SYSTEMS
Table 94 : WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011
Table 95 : TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008 - JULY 2012
Table 96 : NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM 2008 - JULY 2012
Table 97 : NUMBER OF PATENTS BY COMPANY FROM 2008 - JULY 2012
Table 98 : NUMBER OF PATENTS BY COUNTRY FROM 2008 - JULY 2012
Table 99 : NUMBER OF PATENTS BY ASSIGNEE FROM 2008 - JULY 2012
Table 100 : TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008 - JULY 2012
Table 101 : NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008 - JULY 2012
Table 102 : NUMBER OF PATENTS BY COMPANY FROM 2008 - JULY 2012
Table 103 : NUMBER OF PATENTS BY COUNTRY FROM 2008 - JULY 2012
Table 104 : NUMBER OF PATENTS BY ASSIGNEE FROM 2008 - JULY 2012

LIST OF FIGURES

Summary Figure : GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017
Figure SAMPLE FIGURE : GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017
Figure 1 : GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2010 - 2017
Figure 2 : GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2011
Figure 3 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010 - 2017
Figure 4 : MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011
Figure 5 : GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010 - 2017
Figure 6 : GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011
Figure 7 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010 - 2017
Figure 8 : GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011
Figure 9 : GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010 - 2017
Figure 10 : GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011
Figure 11 : GLOBAL MARKET FOR X-RAY AND CT AGENTS BY REGION, 2010-2017
Figure 12 : MARKET SHARE OF X-RAY AND CT REAGENTS BY REGION, 2011
Figure 13 : GLOBAL MARKET FOR IMAGING SYSTEMS, BY TYPE, THROUGH 2017
Figure 14 : MARKET SHARE OF IMAGING SYSTEMS BY TYPE, 2011
Figure 15 : GLOBAL MARKET FOR X-RAY SYSTEMS BY REGION, 2010-2017
Figure 16 : MARKET SHARE OF X-RAY SYSTEMS BY REGION, 2011
Figure 17 : GLOBAL MARKET FOR COMPUTED TOMOGRAPHY SYSTEMS BY REGION, 2010-2017
Figure 18 : MARKET SHARE OF COMPUTED TOMOGRAPHY SYSTEMS BY REGION, 2011
Figure 19 : GLOBAL REVENUE FOR X-RAY AND CT REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017
Figure 20 : GLOBAL REVENUE FOR X-RAY REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017
Figure 21 : X-RAY IMAGING MARKET SHARES, BY APPLICATION, 2011
Figure 22 : GLOBAL REVENUE FOR CT REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017
Figure 23 : COMPUTED TOMOGRAPHY IMAGING MARKET SHARES, BY APPLICATION, 2011
Figure 24 : GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2011
Figure 25 : GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2011
Figure 26 : WORLDWIDE MARKET SHARES OF COMPUTED TOMOGRAPHY SYSTEMS, 2011
Figure 27 : GLOBAL MARKET FOR MRI AGENTS, BY REGION, 2010-2017
Figure 28 : MARKET SHARE OF MRI REAGENTS BY REGION, 2011
Figure 29 : GLOBAL MARKET FOR MRI SYSTEMS, BY REGION, 2010-2017
Figure 30 : MARKET SHARE OF MRI SYSTEMS, BY REGION, 2011
Figure 31 : GLOBAL MARKET FOR MRI SYSTEMS, BY MAGNETIC STRENGTH, 2010-2017
Figure 32 : GLOBAL REVENUE FOR MRI REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017
Figure 33 : MAGNETIC RESONANCE IMAGING MARKET SHARES, BY APPLICATION, 2011
Figure 34 : GLOBAL MARKET SHARES OF MRI CONTRAST AGENTS, 2011
Figure 35 : GLOBAL MARKET SHARES OF MRI IMAGING SYSTEMS, 2011
Figure 36 : GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, 2010-2017
Figure 37 : MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011
Figure 38 : GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, 2010-2017
Figure 39 : MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011
Figure 40 : GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017
Figure 41 : ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011
Figure 42 : GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011
Figure 43 : GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011
Figure 44 : GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2010-2017
Figure 45 : MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011
Figure 46 : GLOBAL MARKET FOR PET SYSTEMS, BY REGION, 2010-2017
Figure 47 : MARKET SHARE OF PET SYSTEMS BY REGION, 2011
Figure 48 : GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, 2010-2017
Figure 49 : positron emission tomography imaging market shares, by application, 2011
Figure 50 : WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, 2011
Figure 51 : WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011
Figure 52 : TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008 - JULY 2012
Figure 53 : TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008 - JULY 2012
Figure 54 : NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012
Figure 55 : NUMBER OF PATENTS BY COUNTRY FROM 2008 - JULY 2012
Figure 56 : NUMBER OF PATENTS BY ASSIGNEE FROM 2008 - JULY 2012